| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |